Back to Results

Xtant Medical Holdings Inc (XTNT)

Xtant Medical Holdings, Inc. is a healthcare company focused on regenerative medicine products and medical devices used by orthopedic and neurological surgeons. Its portfolio includes bone graft and scaffold products, processed allografts, and spinal and orthopedic implant systems designed for applications such as spinal fixation, fusion, joint repair, and related procedures. The company also supplies products used across areas including orthopedics, neurology, podiatry, oral and maxillofacial surgery, genitourinary care, and plastic and reconstructive surgery. Xtant Medical Holdings is headquartered in Belgrade, Montana, and its common stock is listed on the New York Stock Exchange under the symbol XTNT.


Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Market Outlook FAQ

Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Dividend Yield Next Earnings Date Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Free Cash Flow / Net Income
NYSE-XTNT
$0.40
24.9% Upside
Undervalued
$1.03
222.9% Upside
Bargain
Fair
0.0%
November 6, 2026
1.1x
0.4x
44.892 M
62.016 M
36.2%
38.6%
-2.6
6.2%
Valuation • Fair Value

Xtant Medical Holdings Inc (NYSE-XTNT) Fair Value by Valuation Model

Review the available estimates for Xtant Medical Holdings Inc (NYSE-XTNT), including DCF Fair Value, Comps Fair Value.

Primary Valuation Read

Fair Value

$0.40

Estimated upside of 24.9% versus the current market price.

Fair Value Confidence

Med

Confidence level for the primary fair value estimate.

DCF Fair Value

$0.55

Discounted cash flow valuation reference.

Comps Fair Value

$0.38

Comparable-company valuation reference.

Analyst Price Target

$1.03

Analysts imply upside of 222.9%.

How to read these valuation models

Use the 5 available valuation references for Xtant Medical Holdings Inc (NYSE-XTNT) as analytical inputs, not a standalone conclusion. Valuation methods can differ because they rely on different assumptions, time horizons and financial inputs; compare the estimates with the current price and the company’s financial quality.

Profitability • Growth

Profitability & Growth for Xtant Medical Holdings Inc (NYSE-XTNT)

Review the profitability and growth indicators currently supported by the latest data.

Revenue

109.5 M

Current operating scale indicator.

Revenue Forecast

100 M

Forward revenue estimate.

EBITDA

-1.473 M

Current operating profitability reference.

EBITDA Forecast

-4.6 M

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review Xtant Medical Holdings Inc (NYSE-XTNT) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Xtant Medical Holdings Inc (NYSE-XTNT)

Review the financial quality and risk indicators currently supported by the latest data.

Financial Health

Fair

Mixed or neutral financial-health read.

Piotroski Score

5

Mid-range quality score.

Beneish M-Score

-3.67

No elevated caution signal from this screen.

Altman Z-Score

-2.6

Lower score that deserves closer risk review.

FCF / Net Income

6.2%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Xtant Medical Holdings Inc (NYSE-XTNT). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Xtant Medical Holdings Inc (NYSE-XTNT)

Track the upcoming dates and dividend metrics currently supported by the latest data.

Next Earnings Date

November 6, 2026

Days to Earnings

49

Dividend Yield

0.0%

No current dividend yield is indicated.

How to read events and dividends

This section helps investors track time-sensitive items for Xtant Medical Holdings Inc (NYSE-XTNT), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

Xtant Medical Holdings Inc (NYSE-XTNT) Stock Forecast & Technical Outlook

Review Xtant Medical Holdings Inc (NYSE-XTNT) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Sell

The 15-minute technical read for Xtant Medical Holdings Inc (NYSE-XTNT) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Sell

The 1-hour technical read for Xtant Medical Holdings Inc (NYSE-XTNT) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Strong Sell

The daily technical read for Xtant Medical Holdings Inc (NYSE-XTNT) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Sell

The weekly technical read for Xtant Medical Holdings Inc (NYSE-XTNT) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Sell

The monthly technical read for Xtant Medical Holdings Inc (NYSE-XTNT) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for Xtant Medical Holdings Inc (NYSE-XTNT)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Strong Buy

Based on the available recommendation mix, Xtant Medical Holdings Inc (NYSE-XTNT) has a Strong Buy consensus, with 2 buy, 0 hold and 0 sell recommendations in the current data set.

Buy 2
Hold 0
Sell 0
FAQ • Fast Investor Answers

Xtant Medical Holdings Inc (NYSE-XTNT) Stock FAQ

Data-supported answers about Xtant Medical Holdings Inc (NYSE-XTNT), including explicit coverage status where a reliable valuation estimate is not currently available.

Fair Value
$0.40
Estimated upside 24.9%
Valuation Rating
Undervalued
Estimated upside of 24.9%
Analyst Target
$1.03
Implied upside 222.9%
Financial Health
Fair
Current financial-health read

The current fair value estimate for Xtant Medical Holdings Inc (NYSE-XTNT) is $0.40. This implies an estimated upside of 24.9% versus the current market price.

Based on the current fair value estimate, the stock appears undervalued, with estimated upside of 24.9% versus the current market price.

The available analyst price target for Xtant Medical Holdings Inc (NYSE-XTNT) is $1.03. The analyst target implies estimated upside of 222.9%.

The current financial health read for Xtant Medical Holdings Inc (NYSE-XTNT) is Fair. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for Xtant Medical Holdings Inc (NYSE-XTNT) is November 6, 2026.

The latest available data indicates no current dividend yield for Xtant Medical Holdings Inc (NYSE-XTNT).

The current market capitalization listed for Xtant Medical Holdings Inc is 44.892 M.

The current enterprise value listed for Xtant Medical Holdings Inc is 62.016 M. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Xtant Medical Holdings Inc is NYSE-XTNT, and the stock is listed on NYSE.

Xtant Medical Holdings Inc (NYSE-XTNT) is listed on NYSE.

The current debt-to-total-capital ratio listed for Xtant Medical Holdings Inc is 36.2%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Xtant Medical Holdings Inc is 38.6%. Free float helps investors understand how much of the share base is available for public trading.

Similar Healthcare Equipment & Supplies Stocks View more on NYSE

Comparable companies from the same industry, limited to one security per issuer.

ABT NYSE Abbott Laboratories Fair Value Fair Market Cap 177.6 B
ISRG NASDAQ Intuitive Surgical Inc Fair Value Fair Market Cap 139 B
MDT NYSE Medtronic PLC Fair Value Fair Market Cap 117.8 B
SYK NYSE Stryker Corporation Fair Value Fair Market Cap 105.5 B
BSX NYSE Boston Scientific Corp Fair Value Undervalued Market Cap 62.81 B
EW NYSE Edwards Lifesciences Corp Fair Value Fair Market Cap 50.873 B
BDX NYSE Becton Dickinson and Co Fair Value Undervalued Market Cap 49.286 B
MDLN NASDAQ Medline Inc Fair Value Fair Market Cap 41.807 B
IDXX NASDAQ IDEXX Laboratories Inc Fair Value Fair Market Cap 40.289 B
DXCM NASDAQ DexCom Inc Fair Value Fair Market Cap 33.717 B
RMD NYSE ResMed Inc Fair Value Undervalued Market Cap 32.188 B
ALC NYSE Alcon AG Fair Value Undervalued Market Cap 31.559 B
GEHC NASDAQ GE HealthCare Technologies Inc Fair Value Undervalued Market Cap 28.967 B
PHG NYSE Koninklijke Philips NV ADR Fair Value Undervalued Market Cap 24.25 B
STE NYSE STERIS plc Fair Value Undervalued Market Cap 19.991 B
ZBH NYSE Zimmer Biomet Holdings Inc Fair Value Undervalued Market Cap 18.189 B
SOLV NYSE Solventum Corp Fair Value Fair Market Cap 15.123 B
PEN NYSE Penumbra Inc Fair Value Fair Market Cap 12.51 B
BAX NYSE Baxter International Inc Fair Value Undervalued Market Cap 11.788 B
SNN NYSE Smith & Nephew SNATS Inc Fair Value Undervalued Market Cap 11.577 B